Safety and Antitumour Activity of ODM-201 (BAY-1841788) in Chemotherapy-naïve and CYP17 Inhibitor-naïve Patients: Follow-up from the ARADES and ARAFOR Trials
- Resource Type
- Article
- Source
- In
European Urology Focus July 2018 4(4):547-553 - Subject
- Language
- ISSN
- 2405-4569